Methods for treating diseases mediated by ERBB4-positive pro-inflammatory macrophages

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11524055
APP PUB NO 20200353043A1
SERIAL NO

16883695

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are methods and compositions for treating disease-states associated with presence of increased number of ErbB4+ pro-inflammatory macrophages in a subject in need thereof. The methods include providing an activator of ErbB4 and administering a therapeutically effective amount of the activator to the subject. The compositions include an activator of ErbB4. In one embodiment, the activation of ErbB4 is Neuregulin-4.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • CHILDREN'S HOSPITAL LOS ANGELES

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Frey, Mark R Glendale, US 5 18
Schumacher, Michael Glendale, US 37 337

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jun 13, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 13, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 13, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00